Etiology, pathogenesis and management of thoracic aortic aneurysm

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 8, 2007, Pages 418-427

  Ince, Hüseyin ^a   Nienaber, Christoph A ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; PROPRANOLOL;

ANAMNESIS; ANEURYSM SURGERY; AORTA ANEURYSM; AORTA VALVE DISEASE; AWARENESS; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DISEASE MODEL; DRUG EFFICACY; ENDOVASCULAR SURGERY; GENE MUTATION; HEREDITY; HUMAN; HYPERTENSION; INFECTION; INFLAMMATORY DISEASE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; THORACIC AORTA; VASCULAR DISEASE;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; ANGIOGRAPHY; AORTIC ANEURYSM, THORACIC; BLOOD VESSEL PROSTHESIS; COMBINED MODALITY THERAPY; COMORBIDITY; HUMANS; INCIDENCE; MUTATION; PREVALENCE; RISK FACTORS; STENTS;

EID: 34547506609     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0937     Document Type: Review

References (69)

1. Isselbacher EM (2005) Thoracic and abdominal aortic aneurysms. Circulation 111: 816-828
2. Johnston KW et al. (1991) Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 13: 452-458
3. Judge DP and Dietz HC (2005) Marfan's syndrome. Lancet 366: 1965-1976
4. Estrera AL et al. (2006) Thoracic aortic aneurysms. Acta Chir Belg 3: 307-316
5. Sinha I et al. (2006) A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: A role for matrix metalloproteinase 9 and 2. J Vasc Surg 43: 342-348
6. Galis ZS and Khatri JJ (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 90: 251-262
7. Visse R and Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92: 827-839
8. Ikonomidis JS et al. (2005) Effects of deletion of the matrix metalloproteinase 9 gene on development of murine thoracic aortic aneurysms. Circulation 112: 1-242-1-248
9. Wilson WR et al. (2006) Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 133: 438-445
10. LeMaire SA et al. (2005) Matrix metalloproteinases in ascending aortic aneurysms: Bicuspid versus trileaflet aortic valves. J Surg Res 123: 40-48
11. Ikonomidis JS et al. (2006) Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation 114 (Suppl 1): S1365-S1370
12. Chen L et al. (2006) A single nucleotide polymorphism in the matrix metalloprotainase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection. J Thorac Cardiovasc Surg 131: 1045-1052
13. Yoshimura K et al. (2005) Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 11: 1330-1338
14. Kornbluth M et al. (1999) Clinical outcome in the Marfan syndrome with ascending aortic dilatation followed annually by echocardiography. Am J Cardiol 84: 753-755
15. Malfait F et al. (2006) Total absence of the alpha2(1) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems. J Med Genet 43: E36
16. Loeys BL et al. (2006) Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med 355: 788-798
17. Coady MA et al. (1999) Familial patterns of thoracic aortic aneurysms. Arch Sury 134: 361-367
18. Vaughan CJ et al. (2001) Identification of a chromosome 11 q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation 103: 2469-2475
19. Guo D et al. (2001) Familial thoracic aortic aneurysms and dissections: Genetic heterogeneity with a major locus mapping to 5q 13-14. Circulation 103: 2461-2468
20. Hasham SM et al. (2003) Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation 107: 3184-3190
21. Pannu H et al. (2005) Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112: 513-520
22. Glancy DL et al. (2001) Aortic dissection and patent ductus arteriosus in three generations. Am J Cardiol 87: 813-815
23. Khau Van Kien P et al. (2004) Familial thoracic aortic aneurysm/ dissection with patent ductus arteriosus: Genetic arguments for a particular pathophysiological entity. Eur J Hum Genet 12: 173-180
24. Hoffman JI and Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39: 1890-1900
25. Satoda M et al. (2000) Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet 25: 42-46
26. Mani A et al. (2002) Finding genetic contributions to sporadic disease: A recessive locus at 12q24 commonly contributes to patent ductus arteriosus. Proc Natl Acad Sci USA 99: 15054-15059
27. Khau Van Kien P et al. (2005) Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2-p13.13. Circulation 112: 200-206
28. Zhu L et al. (2006) Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection, and patent ductus arteriosus. Nat Genet 38: 343-349
29. Nistri S et al. (1999) Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 82: 19-22
30. Nkomo VT et al. (2003) Bicuspid aortic valve associated with aortic dilatation: A community-based study. Arterioscler Thromb Vasc Biol 23: 351-356
31. de Sa M et al. (1999) Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: Clinical relevance to the Ross procedure. J Thorac Cardiovasc Surg 118: 588-596
32. Huntington K et al. (1997) A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol 30: 1809-1812
33. Fedak PW et al. (2003) Vascular matrix remodeling in patients with bicuspid aortic valve malformations: Implications for aortic dilatation. J Thorac Cardiovasc Surg 126: 797-806
34. Schmid FX et al. (2003) Ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve: Involvement and clinical relevance of smooth muscle cell apoptosis and expression of cell death-initiating proteins. Eur J Cardiothorac Surg 23: 537-543
35. Bongartz T and Matteson EL (2006) Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 18: 10-17
36. Koeppel TA et al. (2004) Mycotic aneurysm of the abdominal aorta with retroperitoneal abscess: Successful endovascular repair. J Vasc Surg 40: 164-166
37. Tin AC et al. (2004) Endovascular repair for multiple Salmonella mycotic aneurysms of the thoracic aorta presenting with Cardiovocal syndrome. Eur J Cardiothorac Surg 26: 221-224
38. Heikkinen MA et al. (2005) Multiple HIV-related aneurysms: Open and endovascular treatment. J Endovasc Ther 12: 405-410
39. Coady MA et al. (1999) Natural history, pathogenesis, and etiology of thoracic aortic aneurysms and dissections. Cardiol Clin 17 615-635
40. Clouse WD et al. (1998) Improved prognosis of thoracic aortic aneurysms: A population-based study. JAMA 280: 1926-1929
41. Coady MA et al. (1999) Surgical intervention criteria for thoracic aortic aneurysms: A study of growth rates and complications. Ann Thorac Surg 67: 1922-1926
42. Davies RR et al. (2002) Yearly rupture or dissection rates for thoracic aortic aneurysms: Simple prediction based on size. Ann Thorac Surg 73: 17-27
43. Bonser RS et al. (2000) Clinical and patho-anatomical factors affecting expansion of thoracic aortic aneurysms. Heart 84: 277-283
44. Ince H and Nienaber CA (2007) Diagnosis and management of patients with aortic dissection. Heart 93: 266-270
45. Lydakis C et al. (2006) Hoarseness as imminent symptom of aortic aneurysm rupture (Orther's syndrome). Int Angiol 25: 232-233
46. Vydt T et al. (2005) Superior vena cave syndrome caused by a pseudoaneurysm of the ascending aorta. Heart 91: E29
47. Johansson G et al. (1995) Ruptured thoracic aortic aneurysms: A study of incidence and mortality rates. J Vasc Surg 21: 985-988
48. Shiga T et al. (2006) Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: Systematic review and meta-analysis. Arch Intern Med 166: 1350-1356
49. von Kodolitsch Y et al. (2004) Chest radiography for the diagnosis of acute aortic syndrome. Am J Med 116: 73-77
50. Koschyk DH et al. (2005) How to guide stent-graft implantation in type B aortic dissection? Comparison of angiography; transesophageal echocardiography, and intravascular ultrasound. Circulation 112 (Suppl 9): S1260-S1264
51. Rubin GD (1997) Helical CT angiography of the thoracic aorta. J Thorac Imaging 12: 128
52. Muhs BE et al. (2006) Dynamic cine-CT angiography for the evaluation of the thoracic aorta; insight in dynamic changes with implications for thoracic endograft treatment. Eur J Vasc Endovasc Surg 32: 532-536
53. Roberts DA (2001) Magnetic resonance imaging of thoracic aortic aneurysm and dissection. Semin Roentgenol 36: 295-308
54. Atar E et al. (2006) MR angiography for abdominal and thoracic aortic aneurysms: Assessment before endovascular repair in patients with impaired renal function. AJR Am J Roentgenol 186: 386-393
55. Davies RR et al. (2006) Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 81: 169-177
56. Shores J et al. (1994) Progression of aortic dilatation and the benefit of long-term beta adrenergic blockade in Marfan's syndrome. N Engl J Med 330: 1335-1341
57. Gersony DR et al. (2007) The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: A meta-analysis. Int J Cardiol 114: 303-308
58. Ejiri J et al. (2003) Oxidative stress in the pathogenesis of thoracic aortic aneurysm: Protective role of statin and angiotensin II type I receptor blocker. Cardiovasc Res 59: 988-996
59. Habashi JP et al. (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312: 117-121
60. Hackam DG et al. (2006) Angiotensin-converting enzyme inhibitors and aortic rupture: A population-based case-control study. Lancet 368: 659-665
61. Gott VL et al. (1999) Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med 340: 1307-1313
62. Elefteriades JA (2002) Natural history of thoracic aortic aneurysms. Indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 74 (Suppl): S1877-S1880
63. Dake MD et al. (1994) Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 331: 1729-1734
64. Nienaber CA et al. (1999) Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement. N Engl J Med 340 1539-1545
65. Ince H et al. (2003) Percutaneous endovascular repair of aneurysm after previous coarctation surgery. Circulation 108: 2967-2970
66. Makaroun MS et al. (2005) Endovascular treatment of thoracic aortic aneurysms: Results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis. J Vasc Surg 41: 1-9
67. Wheatley GH III et al. (2006) Midterm outcome in 158 consecutive Gore TAG thoracic endoprostheses: Single center experience. Ann Thorac Surg 81: 1570-1577
68. Fattori R et al. Talent Thoracic Retrospective Registry (2006) Results of endovascular repair of the thoracic aorta with the Talent Thoracic stent graft: The Talent Thoracic Retrospective Registry. J Thorac Cardiovasc Surg 132: 332-339
69. Demers P et al. (2004) Midterm results of endovascular repair of descending thoracic aortic aneurysms with first-generation stent grafts. J Thorac Cardiovasc Surg 127: 664-67